However, this association may also be driven by APOE4’s contributions toward mechanisms discussed in AD research known to be associated with neurotoxicity, neuronal cell death and synaptic loss, including enhanced amyloid-beta and tau pathology, neuroinflammation, as well as mitochondrial dysfunction (Goel et al., 2022). The gene discussed is MAPT; the disease is Alzheimer disease.